DEAD

Serial Number

85722741

Owner

APRECIA PHARMACEUTICALS, LLC

Attorney

Carole R. Klein

First Use Date

Dec 18, 2013

Filing Date

Sep 6, 2012

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ZIPDOSE Trademark

Serial Number: 85722741 • Registration: 4502502

ZIPDOSE is a trademark filed by APRECIA PHARMACEUTICALS, LLC on September 6, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

APRECIA PHARMACEUTICALS, LLC (39 trademarks)

7200 Industrial Row Drive, Suite 200
Mason, OH 45040

Entity Type: 16

Aprecia Pharmaceuticals Company (23 trademarks)

2010 Cabot Boulevard West, Suite F
Langhorne, PA 19047

Entity Type: 03

Legal Representation

Attorney of Record

Carole R. Klein

794 trademarks filed View all →

Correspondence Address

CAROLE R. KLEIN MORGAN, LEWIS & BOCKIUS LLP

1111 PENNSYLVANIA AVE NW

WASHINGTON

DC 20004-2541

UNITED STATES

Trademark Details

Filing Date

September 6, 2012

Registration Date

March 25, 2014

First Use Anywhere

December 18, 2013

First Use in Commerce

December 18, 2013

Published for Opposition

April 23, 2013

Cancellation Date

October 30, 2020

Filing History

CANCELLED SEC. 8 (6-YR)

Oct 30, 2020 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 25, 2019 REM1

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 31, 2018 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 31, 2018 COAR

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Dec 6, 2017 ASGN

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

May 10, 2017 ASCK

REGISTERED-PRINCIPAL REGISTER

Mar 25, 2014 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 19, 2014 SUNA

LAW OFFICE REGISTRATION REVIEW COMPLETED

Feb 18, 2014 REGV

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 7, 2014 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Feb 6, 2014 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 31, 2014 AITU

USE AMENDMENT FILED

Dec 28, 2013 IUAF

TEAS STATEMENT OF USE RECEIVED

Dec 28, 2013 EISU

TEAS STATEMENT OF USE RECEIVED

Dec 28, 2013 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 20, 2013 EXRA

SOU EXTENSION 1 GRANTED

Dec 18, 2013 EX1G

SOU EXTENSION 1 FILED

Dec 18, 2013 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 18, 2013 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 18, 2013 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 23, 2013 NPUB

PUBLISHED FOR OPPOSITION

Apr 23, 2013 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 3, 2013 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 15, 2013 PREV

ASSIGNED TO LIE

Mar 13, 2013 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 1, 2013 CNSA

EXAMINER'S AMENDMENT ENTERED

Feb 28, 2013 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 28, 2013 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 28, 2013 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 28, 2013 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 29, 2013 GNRN

NON-FINAL ACTION E-MAILED

Jan 29, 2013 GNRT

NON-FINAL ACTION WRITTEN

Jan 29, 2013 CNRT

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Jan 28, 2013 ZZZX

WITHDRAWN FROM PUB - OG REVIEW QUERY

Jan 20, 2013 PBCR

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 4, 2013 CNSA

ASSIGNED TO EXAMINER

Dec 29, 2012 DOCK

NOTICE OF DESIGN SEARCH CODE MAILED

Sep 14, 2012 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 13, 2012 NWOS

NEW APPLICATION ENTERED

Sep 10, 2012 NWAP

Related Trademarks

More from this Owner

APRECIA THE 3DP PHARMACEUTICAL COMPANY

STYNDOVI

INSTYLLIS

KEPSTIDA

More in Same Class

D&C

STEM CELL MEDICINE